An investigational antibody demonstrated an ability to preserve vision in people with geographic atrophy from dry age-related ...

Astellas confirmed today that it will withdraw its EMA filing for avacincaptad pegol as a treatment for eye disorder ...

Four months after Europe's Committee for Medicinal Products for Human Use (CHMP) rejected Apellis’ GA application for Syfovre for a second time, Astellas has withdrawn its application for the approval ...

Meibomian gland dysfunction (MGD) is the major cause of evaporative dry eye disease (EDED ... changes that are detected in human subjects. Atrophic glands also showed evidence of epithelial ...

For treatment, injections deliver a monoclonal antibody to stop the growth of the blood vessels. The hope is that this allows ...

According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics has dosed its first patient in a clinical trial for its innovative ...

CHICAGO -- An investigational dual-action inhibitor for geographic atrophy (GA) significantly slowed disease progression and ...

SAGA topline data has been accepted as a late breaker at the 128th annual meeting of the American Academy of Ophthalmology, being held October 18-21 in Chicago. According to the company, the pilot ...

Objective: Multiple system atrophy (MSA) is commonly associated with rapid eye movement sleep behavior disorder (RBD). Research on the prevalence of RBD in MSA and its effects on MSA patients has ...